Misoprostol
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
40032-161 -
Package NDC
40032-161-01 -
Package NDC
40032-161-06 -
Application number
ANDA091667 -
SPL ID
b702ac6b-e9de-04a9-e053-2995a90a908d -
SPL set ID
a46d05a2-5014-40ff-8f1b-9eca1b0aff3a -
UNII
0E43V0BB57 -
RxCUI
311727 -
RxCUI
317128
What the source publishes
- Labeler
- Novel Laboratories, Inc.
- Active ingredients
- Misoprostol
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Misoprostol",
"splId": "b702ac6b-e9de-04a9-e053-2995a90a908d",
"labels": [
{
"setId": "a46d05a2-5014-40ff-8f1b-9eca1b0aff3a",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a46d05a2-5014-40ff-8f1b-9eca1b0aff3a",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a46d05a2-5014-40ff-8f1b-9eca1b0aff3a"
}
],
"routes": [
"ORAL"
],
"labeler": "Novel Laboratories, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE (40032-161-01)",
"package_ndc": "40032-161-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20120725"
},
{
"sample": false,
"description": "60 TABLET in 1 BOTTLE (40032-161-06)",
"package_ndc": "40032-161-06",
"identifierStatus": "well-formed",
"marketing_start_date": "20120725"
}
],
"productId": "40032-161_b702ac6b-e9de-04a9-e053-2995a90a908d",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "40032-161",
"deaSchedule": null,
"genericName": "Misoprostol",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "MISOPROSTOL",
"strength": "200 ug/1"
}
],
"applicationNumber": "ANDA091667",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20120725",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175785",
"M0017811"
],
"unii": [
"0E43V0BB57"
],
"rxcui": [
"311727",
"317128"
],
"spl_set_id": [
"a46d05a2-5014-40ff-8f1b-9eca1b0aff3a"
],
"pharm_class_cs": [
"Prostaglandins E, Synthetic [CS]"
],
"pharm_class_epc": [
"Prostaglandin E1 Analog [EPC]"
],
"manufacturer_name": [
"Novel Laboratories, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:40032-161_b702ac6b-e9de-04a9-e053-2995a90a908d"